Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients

Table 1 Baseline and demographics of the study population (full analysis set)

Variables	n (missing)	Values, mean ± SD; n (%)
Age (yr)	114 (0)	24.5 ± 6.3
Average days of menstrual cycles in the	96 (18)	63.7 ± 25.5
Last three months
Average days of menstrual periods in the	108 (6)	7.1 ± 6.2
Last three months
Urine pregnancy test (enrollment)	114 (0)
Negative		1 (0.9)
Positive		0 (0.0)
Not applicable		5 (4.4)
Deferred		108 (94.7)
Diagnosis of polycystic ovaries syndrome 114 (0)
Yes		41 (36.0)
No		73 (64.0)